SEC Form 4Coverage since Aug 3, 2026
$COCP insider trading
Over the last 12 months, Cocrystal Pharma insiders reported 2 buys totaling $80K and no sales across SEC Form 4 filings.
- Bought · 12m
- $80K 2 events
- Sold · 12m
- — 0 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $COCP · 12Mvia TradingView
Top insiders · 12m
FROST PHILLIP MD ET AL—2× · $80K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | FROST PHILLIP MD ET ALD·10% | ▲ Buy | 10,000 | $0.98 | $10K | +0.5% | indirect |
| Aug 3, 2026 | FROST PHILLIP MD ET ALD·10% | ▲ Buy | 75,000 | $0.94 | $71K | +3.9% | indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $COCP feed.